Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat NMDAR2A ELISA Kit (AC3114)
Cat.#: ASET-1703
Specifications
Description Rat NMDAR2A ELISA Kit allows for the in vitro quantitative determination of rat NMDAR2A concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1922 Porcine Heme Oxygenase 1 ELISA Kit (AC3333) Quantitative inquiry ASET-2011 Human Kappa Opioid Receptor ELISA Kit (AC3422) Quantitative inquiry ASET-1233 Human TAS2R38 ELISA Kit (AC2644) Quantitative inquiry ASET-1417 Mouse Adenosine Receptor A2a ELISA Kit (AC2828) Quantitative inquiry ASET-2255 Mouse Semaphorin 7a ELISA Kit (AC3666) Quantitative inquiry ASET-1784 Mouse DLL1 ELISA Kit (AC3195) Quantitative inquiry ASET-1645 Human CD24 ELISA Kit (AC3056) Quantitative inquiry ASET-1464 Human L1CAM ELISA Kit (AC2875) Quantitative inquiry ASET-1585 Rat iNOS ELISA Kit (AC2996) Quantitative inquiry ASET-2470 Human MAS1L ELISA Kit (AC3881) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket